Xeris Pharmaceuticals | XERS - Market Capitalization


Xeris Pharmaceuticals reported $938.2M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Celltrion KRW 40.04T 3.19T Sep/2025
Cspc Pharmaceutical CNY 107.03B 26.09B Sep/2025
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Divis Laboratories Ltd INR 1.62T 72.34B Feb/2026
Eli Lilly USD 1.01T 3.37B Feb/2026
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 580.82M 31.21M Jun/2025
Laboratorios Farma EUR 3.68B 430.05M Jan/2026
Malin Corporation EUR 150.45M 12.13M Jan/2026
Medical Developments International AUD 61.96M 16.34M Jun/2025
Nektar Therapeutics USD 113M 4M Sep/2023
Neuren Pharmaceuticals AUD 1.75B 152.5M Jun/2025
Organigram Holdings CAD 191.77M 187.03M Feb/2026
Ovoca Bio EUR 7.54M 4.28M Jun/2022
Pacira USD 1.16B 51M Sep/2025
Perrigo USD 2.95B 698M Sep/2025
Pharma Mar EUR 1.63B 241.7M Sep/2025
Qiagen NV USD 9.46B 440.29M Feb/2026
Sartorius EUR 8.12B 8.29B Feb/2026
Sino Biopharmaceutical CNY 90.06B 33.55B Jun/2025
Supernus Pharmaceuticals USD 2.92B 67M Feb/2026
Zz Pientze Pharmaceu CNY 118.73B 1.94B Sep/2025